Construction and immunogenicity of recombinant fowlpox vaccines coexpressing HA of AIV H5N1 and chicken IL18 Fulltext Access 8 Pages 2006
Serum antibodies to putative proteinase maturation protein A in children with acute otitis media Fulltext Access 8 Pages 2006
Immunological responses after immunisation of mice with microparticles containing antigen and single stranded RNA (polyuridylic acid) Fulltext Access 8 Pages 2006
Low-dose intraperitoneal Freund's adjuvant: Toxicity and immunogenicity in mice using an immunogen targeting amyloid-β peptide Fulltext Access 8 Pages 2006
Potential of KM+ lectin in immunization against Leishmania amazonensis infection Fulltext Access 8 Pages 2006
Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71 Fulltext Access 8 Pages 2006
Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999–2004 Fulltext Access 8 Pages 2006
The sequence of vaccinations and increased female mortality after high-titre measles vaccine: Trials from rural Sudan and Kinshasa Fulltext Access 8 Pages 2006
Interchangeability of Hepatitis A boosters, Avaxim® and Vaqta®, in healthy adults following a primary dose of the combined typhoid/Hepatitis A vaccine Viatim® Fulltext Access 8 Pages 2006
Recombinant hepatitis B large surface antigen, successfully produced in Escherichia coli, stimulates T-cell response in mice Fulltext Access 8 Pages 2006
Estimating the risk population in relation to influenza vaccination policy Fulltext Access 8 Pages 2006
Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus Fulltext Access 8 Pages 2006
WHO informal consultation on scientific basis for regulatory evaluation of candidate human vaccines from plants, Geneva, Switzerland, 24–25 January 2005 Fulltext Access 8 Pages 2006
Influence of bovine respiratory syncytial virus F glycoprotein N-linked glycans on in vitro expression and on antibody responses in BALB/c mice Fulltext Access 8 Pages 2006
Studies on in vitro expression and in vivo immunogenicity of a recombinant MVA HIV vaccine Fulltext Access 8 Pages 2006
Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge Fulltext Access 8 Pages 2006
Comparison of potential protection induced by three vaccination strategies (DNA/DNA, Protein/Protein and DNA/Protein) against Leishmania major infection using Signal Peptidase type I in BALB/c mice Fulltext Access 8 Pages 2006
Adherence of recombinant pneumococcal surface adhesin A (rPsaA)-coated particles to human nasopharyngeal epithelial cells for the evaluation of anti-PsaA functional antibodies Fulltext Access 8 Pages 2006
Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002–2003) Fulltext Access 8 Pages 2006
Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6® cells: A novel RP-HPLC method Fulltext Access 8 Pages 2006
Future acceptance of adolescent human papillomavirus vaccination: A survey of parental attitudes Fulltext Access 8 Pages 2006
An in vitro immune response model to determine tetanus toxoid antigen (vaccine) specific immunogenicity: Selection of sensitive assay criteria Fulltext Access 8 Pages 2006
Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN®: Results of two large phase 3 clinical studies Fulltext Access 8 Pages 2006
Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays Fulltext Access 8 Pages 2006
Direct access in primary care and patient satisfaction: A European study Fulltext Access 8 Pages 2006
Priority setting of public spending in developing countries: Do not try to do everything for everybody Fulltext Access 8 Pages 2006
Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer Fulltext Access 8 Pages 2006
Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays—an update Fulltext Access 8 Pages 2006
Expressions of Bovine IFN-γ and Foot-and-Mouth Disease VP1 antigen in P. pastoris and their effects on mouse immune response to FMD antigens Fulltext Access 8 Pages 2006
Vaccination of mice with DNA vaccine induces the immune response and partial protection against T. spiralis infection Fulltext Access 8 Pages 2006
Systemic immune responses in sheep, induced by a novel nano-bead adjuvant Fulltext Access 8 Pages 2006
Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein Fulltext Access 8 Pages 2006
A novel synthetic adjuvant effectively enhances the immunogenicity of the influenza vaccine Fulltext Access 8 Pages 2006
Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons—Liberia, 2004 Fulltext Access 8 Pages 2006
Genetic fusion of proteins to the SIV Tat protein enhances their immunogenicity Fulltext Access 8 Pages 2006
Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for generation of CTL responses to peptide and protein antigens Fulltext Access 8 Pages 2006
Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: One year follow-up study Fulltext Access 8 Pages 2006
Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice Fulltext Access 8 Pages 2006
Protective immunization against “Candidatus Helicobacter suis” with heterologous antigens of H. pylori and H. felis Fulltext Access 8 Pages 2006
Development of an opsonin inhibition assay for evaluation of complex polysaccharide protective epitopes Fulltext Access 8 Pages 2006
Candidate peptide-vaccines induced immunity against CSFV and identified sequential neutralizing determinants in antigenic domain A of glycoprotein E2 Fulltext Access 8 Pages 2006
Ganglioside GM1-binding peptides as adjuvants of antigens inoculated by the intranasal route Fulltext Access 8 Pages 2006
Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens Fulltext Access 8 Pages 2006
4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine Fulltext Access 8 Pages 2006
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential Fulltext Access 8 Pages 2006
Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice Fulltext Access 8 Pages 2006
Immunization with gp120-depleted whole killed HIV immunogen and a second-generation CpG DNA elicits strong HIV-specific responses in mice Fulltext Access 8 Pages 2006
Long-term egg-yolk adaptation of the Orientia tsutsugamushi for preparation of a formalinized immunogen Fulltext Access 8 Pages 2006
Interleukin-12 induces a Th1-like response to Burkholderia mallei and limited protection in BALB/c mice Fulltext Access 8 Pages 2006
Intranasal immunization of BALB/c mice with enterotoxigenic Escherichia coli colonization factor CS6 encapsulated in biodegradable poly(dl-lactide-co-glycolide) microspheres Fulltext Access 8 Pages 2006
Immunologic responses of bison to vaccination with Brucella abortus strain RB51: Comparison of parenteral to ballistic delivery via compressed pellets or photopolymerized hydrogels Fulltext Access 8 Pages 2006
Haemolytic activities and adjuvant effect of Bupleurum chinense saponins on the immune responses to ovalbumin in mice Fulltext Access 8 Pages 2006
Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs Fulltext Access 8 Pages 2006
Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice Fulltext Access 8 Pages 2006
Naturally occurring antibodies for the group B streptococcal surface immunogenic protein (Sip) in pregnant women and newborn babies Fulltext Access 8 Pages 2006
Optimal organization of a polypeptide-based candidate cancer vaccine composed of cryptic tumor peptides with enhanced immunogenicity Fulltext Access 8 Pages 2006
HIV vaccine acceptability among communities at risk: The impact of vaccine characteristics Fulltext Access 8 Pages 2006
Expression of an anti-botulinum toxin A neutralizing single-chain Fv recombinant antibody in transgenic tobacco Fulltext Access 8 Pages 2006
Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis Fulltext Access 8 Pages 2006
Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2–7 months of age Fulltext Access 8 Pages 2006
Efficient systemic and mucosal responses against the HIV-1 Tat protein by prime/boost vaccination using the lipopeptide MALP-2 as adjuvant Fulltext Access 8 Pages 2006
Diphtheria tetanus pertussis poliomyelitis vaccination and reported atopic disorders in 8–12-year-old children Fulltext Access 8 Pages 2006
Immune response induced by Salmonella typhimurium defective in ppGpp synthesis Fulltext Access 8 Pages 2006
Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvert Fulltext Access 8 Pages 2006
Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults Fulltext Access 8 Pages 2006
Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment Fulltext Access 8 Pages 2006
Dynamics of dendritic cell migration and the subsequent induction of protective immunity in the lung after repeated airway challenges by nontypeable Haemophilus influenzae outer membrane protein Fulltext Access 8 Pages 2006
Protection against L3 induced Brugia malayi infection in Mastomys coucha pre-immunized with BmAFII fraction of the filarial adult worm Fulltext Access 8 Pages 2006
An immunogenicity study of a newly fusion protein Cna-FnBP vaccinated against Staphylococcus aureus infections in a mice model Fulltext Access 8 Pages 2006
Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae Fulltext Access 8 Pages 2006
Age-specific changes in the female–male mortality ratio related to the pattern of vaccinations: An observational study from rural Gambia Fulltext Access 8 Pages 2006
Replication and immunoactivity of the recombinant Peromyscus maniculatus cytomegalovirus expressing hantavirus G1 glycoprotein in vivo and in vitro Fulltext Access 8 Pages 2006
Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis Fulltext Access 8 Pages 2006
Immunogenicity and cytoadherence of recombinant heparin binding haemagglutinin (HBHA) of Mycobacterium avium subsp. paratuberculosis: Functional promiscuity or a role in virulence? Fulltext Access 8 Pages 2006
Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology? Fulltext Access 8 Pages 2006
Phase II randomized, placebo-controlled trial of M. vaccae-derived protein (PVAC®) for the treatment of psoriasis Fulltext Access 8 Pages 2006
Cross-clade recognition and neutralization by the V3 region from clade C human immunodeficiency virus-1 envelope Fulltext Access 8 Pages 2006
Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice Fulltext Access 8 Pages 2006
The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate Fulltext Access 8 Pages 2006
Decreased cytotoxic T cell activity generated by co-administration of PSA vaccine and CpG ODN is associated with increased tumor protection in a mouse model of prostate cancer Fulltext Access 8 Pages 2006
Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes Fulltext Access 8 Pages 2006
Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children Fulltext Access 8 Pages 2006
Heat labile enterotoxin of E. coli: a potential adjuvant for transcutaneous cancer immunotherapy Fulltext Access 8 Pages 2006
Imprinting of BALB/c mice with low Leishmania infantum parasite dose markedly protects spleen against high-dose challenge Fulltext Access 8 Pages 2006
The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection Fulltext Access 8 Pages 2006
Use of National Health Insurance database to evaluate the impact of public varicella vaccination program on burden of varicella in Taiwan Fulltext Access 8 Pages 2006
Efficacy of strain RB51 vaccine in heifers against experimental brucellosis Fulltext Access 8 Pages 2006
The HIV-1 matrix protein p17 can be efficiently delivered by intranasal route in mice using the TLR 2/6 agonist MALP-2 as mucosal adjuvant Fulltext Access 8 Pages 2006
Hepatitis B infection among health workers in Uganda: Evidence of the need for health worker protection Fulltext Access 8 Pages 2006